Conjunctival Neoplasm — Trials

Conjunctival Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

14 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05628883	Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma	completed	Phase 1	17	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Apr 2, 2026	clinicaltrials
NCT01154452	Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma	completed	Phase 1 / Phase 2	78	National Cancer Institute (NCI)NIH	1	Aug 15, 2018	clinicaltrials
NCT00456495	Effect of Ranibizumab on Malignant Conjunctival Neoplasia	completed	Phase 1	5	The New York Eye Cancer CenterOTHER	1	Jul 21, 2017	clinicaltrials
NCT00471471

Data updated 22 days agoSource updated Apr 2, 2026source: clinicaltrials